Modafinil Film-Coated Tablets in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

莫达非尼 中止 安慰剂 注意缺陷多动障碍 心理学 医学 精神科 麻醉 病理 替代医学
作者
James M. Swanson,Laurence L. Greenhill,Frank A. López,Andrew Sedillo,Craig Q. Earl,John Jiang,Joseph Biederman
出处
期刊:The Journal of Clinical Psychiatry [Physicians Postgraduate Press, Inc.]
卷期号:67 (01): 137-147 被引量:103
标识
DOI:10.4088/jcp.v67n0120
摘要

OBJECTIVE: The objective of this fixed-dose study was to determine the efficacy and safety of a new formulation of modafinil (modafinil film-coated tablets) in children and adolescents with attention-deficit/hyperactivity disorder (ADHD). In addition, the effect of abrupt discontinuation of modafinil was evaluated in a 2-week observation period. METHOD: Patients aged 6 to 17 years with DSM-IV-TR-defined ADHD were randomly assigned to 7 weeks of double-blind treatment with modafinil or placebo in a 2:1 ratio, followed by abrupt discontinuation of modafinil and a 2-week, double-blind observation period in which 46% of patients receiving modafinil were switched to placebo without tapering and half continued to receive modafinil. Study drug was administered once daily and titrated over the first 7 to 9 days to daily doses of 340 mg for patients < 30 kg or 425 mg for patients > or = 30 kg. Assessment instruments included the Attention-Deficit/ Hyperactivity Disorder Rating Scale-IV (ADHD-RS-IV) School and Home Versions and Clinical Global Impressions-Improvement scale (CGI-I). The study was conducted from November 2003 to June 2004. RESULTS: A total of 190 patients were randomly assigned to receive modafinil (340 mg, N = 44; 425 mg, N = 82) or placebo (N = 64). 189 patients were evaluated for safety. Modafinil significantly improved symptoms of ADHD as shown by reductions in ADHD-RS-IV School Version total scores compared with placebo at all visits (p < or = .009), including the final visit of the double-blind phase (p < .0001). With modafinil, ADHD-RS-IV School Version mean total scores changed from 37.8 at baseline to 29.3 at week 1 and 20.7 at final visit; corresponding placebo values were 36.6, 32.8, and 28.4, respectively; effect size at final visit was 0.76 (95% CI = 0.63 to 0.88). Total scores on the ADHD-RS-IV Home Version were also significantly reduced at all visits (p < or = .022) and final visit (p = .001) in patients receiving modafinil compared with those receiving placebo. Significantly higher proportions of patients receiving modafinil were rated "much improved" or "very much improved" in overall clinical condition (CGI-I) at all visits compared with patients receiving placebo (p < .001). No withdrawal symptoms were observed when modafinil was abruptly discontinued at the beginning of the final 2-week observation period. Modafinil was generally well tolerated. Insomnia, headache, and decreased appetite were the most commonly reported adverse events. Sixty-three percent of patients who received modafinil completed the study; 13% discontinued because of lack of efficacy; 10%, because of adverse events; and 13%, for other reasons (e.g., consent withdrawn, lost to follow-up). CONCLUSION: Modafinil significantly improved symptoms of ADHD both at school and at home and was well tolerated by children and adolescents. Abrupt discontinuation of modafinil was not associated with symptoms of withdrawal or with rebound of symptoms of ADHD.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Duang完成签到,获得积分10
刚刚
科研通AI6.3的应助被wxl采纳,获得10
1秒前
上官若男的应助被西余采纳,获得10
2秒前
FashionBoy的应助被JIAJIAJIA采纳,获得10
2秒前
核桃发布了新的文献求助10
3秒前
杪春发布了新的文献求助10
3秒前
科研通AI6.3的应助被zyy采纳,获得10
3秒前
y神发布了新的文献求助10
3秒前
何东玲发布了新的文献求助10
4秒前
曾经二娘完成签到,获得积分10
4秒前
if的应助被ubless607采纳,获得50
4秒前
水煮电吹风的应助被zhangmingyang采纳,获得10
5秒前
Dd18753801528完成签到,获得积分10
5秒前
Lucas的应助被飞飞飞飞飞飞采纳,获得10
5秒前
6秒前
ʚᵗᑋᵃᐢᵏ ᵞᵒᵘɞ完成签到,获得积分0
6秒前
无花果的应助被何东玲采纳,获得10
8秒前
大萌发布了新的文献求助10
8秒前
YYYYSO完成签到,获得积分10
8秒前
风中子轩完成签到,获得积分10
9秒前
10秒前
CipherSage的应助被叉叉采纳,获得10
11秒前
11秒前
李健的小迷弟的应助被Tuniverse_采纳,获得10
11秒前
养乐多完成签到,获得积分10
12秒前
12秒前
loess完成签到,获得积分10
12秒前
12秒前
12秒前
yz完成签到,获得积分10
12秒前
13秒前
huichenggong完成签到,获得积分10
13秒前
13秒前
大个的应助被糖布里部采纳,获得10
14秒前
何东玲完成签到,获得积分10
14秒前
zly关闭了zly的文献求助
15秒前
17秒前
爆米花的应助被Duang采纳,获得10
17秒前
LJN.up的应助被Tuniverse_采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181949
求助须知:如何正确求助?哪些是违规求助? 9571702
关于积分的说明 21819272
捐赠科研通 7778399
什么是DOI,文献DOI怎么找? 3433572
关于科研通互助平台的介绍 2557769
邀请新用户注册赠送积分活动 2479630